Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| neuron | 5 studies | 51% ± 18% | |
| Mueller cell | 5 studies | 37% ± 20% | |
| amacrine cell | 4 studies | 40% ± 21% | |
| retinal rod cell | 4 studies | 33% ± 11% | |
| retina horizontal cell | 3 studies | 35% ± 16% | |
| retinal cone cell | 3 studies | 42% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 5 studies | 30% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 1174.22 | 458 / 459 | 48% | 1.42 | 533 / 1118 |
| muscle | 98% | 265.69 | 789 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 31% | 91.30 | 81 / 258 | 67% | 48.29 | 153 / 230 |
| thymus | 92% | 188.68 | 604 / 653 | 2% | 0.04 | 15 / 605 |
| prostate | 65% | 116.82 | 159 / 245 | 28% | 1.76 | 140 / 502 |
| bladder | 76% | 102.57 | 16 / 21 | 13% | 0.97 | 68 / 504 |
| brain | 39% | 729.55 | 1036 / 2642 | 46% | 1.74 | 327 / 705 |
| intestine | 83% | 227.24 | 806 / 966 | 2% | 0.04 | 9 / 527 |
| adipose | 84% | 220.78 | 1016 / 1204 | 0% | 0 | 0 / 0 |
| skin | 62% | 139.24 | 1116 / 1809 | 17% | 1.06 | 81 / 472 |
| blood vessel | 76% | 276.59 | 1011 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 64% | 130.29 | 924 / 1445 | 10% | 0.31 | 19 / 183 |
| ovary | 63% | 62.82 | 114 / 180 | 3% | 0.16 | 14 / 430 |
| stomach | 47% | 73.06 | 167 / 359 | 4% | 0.08 | 12 / 286 |
| heart | 42% | 42.53 | 362 / 861 | 0% | 0 | 0 / 0 |
| spleen | 42% | 37.86 | 101 / 241 | 0% | 0 | 0 / 0 |
| uterus | 15% | 12.61 | 25 / 170 | 9% | 0.89 | 43 / 459 |
| eye | 0% | 0 | 0 / 0 | 18% | 1.84 | 14 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.42 | 4 / 45 |
| pancreas | 0% | 0 | 0 / 328 | 8% | 0.22 | 15 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 1.02 | 2 / 29 |
| lung | 2% | 1.30 | 11 / 578 | 4% | 0.14 | 51 / 1155 |
| kidney | 1% | 0.71 | 1 / 89 | 3% | 0.48 | 26 / 901 |
| liver | 0% | 0 | 0 / 226 | 1% | 0.11 | 6 / 406 |
| peripheral blood | 0% | 0.24 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0043010 | Biological process | camera-type eye development |
| GO_0008283 | Biological process | cell population proliferation |
| GO_0001654 | Biological process | eye development |
| GO_0009653 | Biological process | anatomical structure morphogenesis |
| GO_0005634 | Cellular component | nucleus |
| GO_0016779 | Molecular function | nucleotidyltransferase activity |
| GO_0005525 | Molecular function | GTP binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | MAB21L1 |
| Protein name | Putative nucleotidyltransferase MAB21L1 (EC 2.7.7.-) (Protein mab-21-like 1) Putative nucleotidyltransferase MAB21L1 (Protein mab-21-like 1) |
| Synonyms | Nbla00126 CAGR1 |
| Description | FUNCTION: Putative nucleotidyltransferase required for several aspects of embryonic development including normal development of the eye . It is unclear whether it displays nucleotidyltransferase activity in vivo . Binds single-stranded RNA (ssRNA) . . |
| Accessions | Q13394 F1T0A2 ENST00000379919.6 ENST00000707125.1 |
